UCLA Precision Health experts aim to transform prevention and treatment of disease

Precision medicine has been a major priority for UCLA Health, underscored by the 2016 launch of the Institute for Precision Health at UCLA.

That continuing effort was highlighted by the inaugural California Precision Health Summit focused on cancer evolution held at UCLA on February 6 at Carnesale Commons. The all-day summit included presentations by top researchers in precision medicine from UCLA Health, UCLA's Jonsson Comprehensive Cancer Center and from leading research institutes at Stanford University, the United Kingdom's Francis Crick Institute and CURK Manchester Institute at the University of Manchester.

The aim of precision health is to revolutionize health prevention and the treatment of disease by better predicting which people may be susceptible to certain illnesses and finding treatments that are tailored more closely to their individual needs. The field involves the study of lifestyle, environment and genetic factors that provide insights into the health or illness of individuals or certain groups.

Read the full UCLA press release.

The summit was sponsored by the Institute for Precision Health at UCLA, UCLA Clinical and Translational Science Institute and UCLA Jonsson Comprehensive Cancer Center. 

Image source: UCLA

Image caption: The summit included presentations from top researchers in precision medicine from UCLA Health, UCLA's Jonsson Comprehensive Cancer Center, Stanford University, the United Kingdom's Francis Crick Institute and CURK Manchester Institute at the University of Manchester.